Cubist Systematic Strategies, LLC Adverum Biotechnologies, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.33 $16,311 - $25,336	-10,874 Reduced 35.35%	19,884 $29,000
Q2 2023 Aug 14, 2023	SELL	$0.68 - $1.59 $508 - $1,189	-748 Reduced 2.37%	30,758 $48,000
Q1 2023 May 15, 2023	BUY	$0.62 - $0.85 $19,533 - $26,780	31,506 New	31,506 $22,000
Q3 2022 Nov 14, 2022	SELL	$0.96 - $9.68 $2,811 - $28,352	-2,929 Reduced 16.92%	14,377 $14,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $1.34 $2,109 - $3,489	2,604 Added 17.71%	17,306 $21,000
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $63,241 - $100,261	-51,416 Reduced 77.76%	14,702 $19,000
Q4 2021 Feb 14, 2022	BUY	$1.74 - $2.4 $7,010 - $9,669	4,029 Added 6.49%	66,118 $116,000
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $43,409 - $75,132	-20,870 Reduced 25.16%	62,089 $135,000
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $193,331 - $607,611	57,539 Added 226.35%	82,959 $290,000
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $235,389 - $365,031	25,420 New	25,420 $251,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $1.35 Million - $1.95 Million	-136,966 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $1.41 Million - $2.96 Million	136,966 New	136,966 $1.41 Million
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $264,430 - $794,840	-31,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $58,333 - $119,299	-7,310 Reduced 19.08%	31,000 $303,000
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $196,147 - $468,148	38,310 New	38,310 $441,000
Q1 2019 May 15, 2019	SELL	$3.03 - $6.02 $84,355 - $167,596	-27,840 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.87 - $5.92 $79,900 - $164,812	27,840 New	27,840 $88,000
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $60,889 - $102,835	-13,531 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $168,084 - $218,826	-31,714 Reduced 70.09%	13,531 $72,000
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $165,144 - $359,697	45,245 New	45,245 $262,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account